Can metoprolol tartrate tablets not be used for bronchial asthma?
Metoprolol tartrate tablets should not be used in patients with bronchial asthma. The specific analysis is as follows:
Bronchial asthma is a relatively common respiratory disease. Currently, its etiology in clinical practice is broad, but it is mostly related to genetic factors or the patient's inherent allergic predisposition. When exposed to fine particles such as dust or pollen, symptoms may worsen, including difficulty breathing and coughing, and the condition is typically characterized by sudden onset. Metoprolol tartrate is a β1-receptor blocker, which can slow down an elevated heart rate when administered. However, during an asthma attack, the heart naturally increases its pacing to maintain adequate circulation. Using metoprolol tartrate at this time may suppress the heart's contractile ability, potentially worsening the condition or leading to syncope, suffocation, or other serious complications.
Patients are advised to seek timely medical evaluation and treatment when experiencing symptoms. Additionally, they should avoid environments with high levels of dust or allergens in daily life to prevent disease exacerbation.